Education
About Us
Working with TipRanks
Follow Us
Adaptive Biotechnologies Corp (ADPT)
NASDAQ:ADPT
Earnings Data
Report Date
Oct 30, 2025After Close (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
-0.2Last Year’s EPS
-0.22Same Quarter Last Year
Strong Buy
Based on 8 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflects a robust performance with strong revenue growth, successful profitability in the MRD business, and improved financial metrics. While there are dependencies on milestone payments and future collaborations for continued growth, the positive aspects significantly outweigh the challenges.Company Guidance -
Q3 2025
MRD Business Profitability
The MRD business achieved profitability this quarter, delivering approximately $2 million in positive adjusted EBITDA, with a 42% year-over-year revenue growth.
clonoSEQ Revenue Growth
clonoSEQ revenue grew 57% year-over-year in the second quarter, driven by strong demand across all reimbursed indications.
Sequencing Gross Margin Improvement
Total company sequencing gross margin improved by 14 percentage points year-over-year to 64%.
Increased Full-Year Guidance
Full year MRD revenue guidance was raised to a range of $190 million to $200 million, up from the previous range of $180 million to $190 million.
Strong Cash Position
Cash burn for the quarter was approximately $11 million, a 36% improvement over the same period last year, ending with a solid cash position of $222 million.
Positive Clinical and Pharma Volume Growth
Delivered over 25,300 tests, up 37% versus prior year, with blood-based testing representing 44% of MRD tests, up 40% from a year ago.
NCCN Guidelines Update
NCCN guidelines for multiple myeloma were updated to strengthen support for ID testing at diagnosis, reducing barriers to MRD testing and helping drive volume.
ADPT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ADPT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 05, 2025 | $11.05 | $11.69 | +5.79% |
May 01, 2025 | $7.36 | $9.84 | +33.70% |
Feb 11, 2025 | $7.80 | $7.55 | -3.21% |
Nov 07, 2024 | $5.63 | $5.82 | +3.37% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Adaptive Biotechnologies Corp (ADPT) report earnings?
Adaptive Biotechnologies Corp (ADPT) is schdueled to report earning on Oct 30, 2025, After Close (Confirmed).
What is Adaptive Biotechnologies Corp (ADPT) earnings time?
Adaptive Biotechnologies Corp (ADPT) earnings time is at Oct 30, 2025, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ADPT EPS forecast?
ADPT EPS forecast for the fiscal quarter 2025 (Q3) is -0.2.